Efficacy and safety data on pretomanid for drug-resistant TB
OBJECTIVE: To summarise the efficacy and safety of pretomanid (Pa) based regimens in patients with drug-resistant TB (DR-TB). METHODS: We included clinical trials, operational research and observational studies reporting the efficacy and safety of Pa-based regimens in DR-TB. The duration of the trea...
Saved in:
| Main Authors: | H.T.T. Thuy, C. Padmapriyadarsini, C. Chuchottaworn, S. Foraida, S. Hadigal, A.R. Birajdar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Union Against Tuberculosis and Lung Disease (The Union)
2025-02-01
|
| Series: | IJTLD Open |
| Subjects: | |
| Online Access: | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2025/00000002/00000002/art00004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Second-line drug resistance among multidrug-resistant tuberculosis patients in Ethiopia: A laboratory-based surveillance
by: Getu Diriba, et al.
Published: (2025-05-01) -
Immediate Outcomes of Surgical Treatment for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
by: D. B. Giller, et al.
Published: (2024-08-01) -
Outbreak Caused by Multidrug-Resistant Mycobacterium Tuberculosis with Unusual Combination of Resistance Mutations, Northern Argentina, 2006–2022
by: Roxana Paul, et al.
Published: (2025-03-01) -
Treatment outcomes of extensive drug resistant tuberculosis in the penitentiary system of the Russian Federation
by: S. A. Sterlikov, et al.
Published: (2018-11-01) -
The New Definition and Epidemiology of Extensive Drug Resistant Tuberculosis in 2020
by: S. A. Sterlikov, et al.
Published: (2023-04-01)